All News

2019

September

Media Release / Sep 03, 2019

Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine

Read More

August

Biosimilars in the US: Time to stop the towels blocking the deckchairs
Featured News / Aug 28, 2019

Biosimilars in the US: Time to stop the towels blocking the deckchairs

Richard Saynor via LinkedIn

Read More
Media Release / Aug 09, 2019

Sandoz will appeal District Court of New Jersey ruling in biosimilar Erelzi® (etanercept-szzs) US patent case

Read More

July

Media Release / Jul 22, 2019

Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis

Read More
Media Release / Jul 18, 2019

Novartis delivers strong sales, double digit core operating income growth and launches Zolgensma and Piqray in second quarter; sales and profit guidance increased

Read More
Media Release / Jul 09, 2019

Sandoz extends SYMJEPI™ (epinephrine) Injection launch to US pharmacies to help improve patient access to life-saving medicine

Read More
Featured News / Jul 02, 2019

Why opening the door to generics on day one is no brainer

There is no denying that having more choice increases our flexibility, autonomy, freedom and gives more control back to us.

Read More
Media Release / Jul 02, 2019

Sandoz launches oncology generic gefitinib in 13 EU countries at loss of market exclusivity, expanding access to essential medicine

Read More

June

Media Release / Jun 27, 2019

Sandoz enters agreement with Kit Check to track, automate restocking of products in U.S. hospitals

Read More
Media Release / Jun 14, 2019

New Sandoz biosimilar adalimumab data confirms switching from reference biologic has no impact on safety or efficacy

Read More